PHI with Senile coxarthrosis
How does this condition affect your private health insurance?
Malum coxae senile, commonly known as osteoarthritis of the hip, is a degenerative joint disease characterized by the breakdown of cartilage in the hip joint. This progressive condition primarily affects older adults, leading to pain, stiffness, and reduced range of motion. The cartilage erosion causes bones to rub against each other, forming bone spurs (osteophytes) and altering joint mechanics. Symptoms often worsen over time, impacting daily activities like walking and climbing stairs. Inflammation and muscle weakness may also contribute to discomfort and functional limitations, eventually necessitating medical intervention.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Gradual onset, typically evolving over months to several years as symptoms become noticeable.
Duration of Illness (Lifetime)
Chronic and progressive, lasting for the remainder of the individual's life.
Cost of Treatment (Initial)
Moderate (e.g., doctor visits, physical therapy, pain medication, anti-inflammatory drugs)
Cost of Treatment (Lifetime)
High to very high (includes long-term conservative management, potential injections, and possibly hip replacement surgery which is costly).
Mortality Rate
Very low (not directly life-threatening; potential indirect risks from immobility or surgical complications are rare).
Risk of Secondary Damages
High (e.g., chronic pain, significant mobility impairment, muscle atrophy, gait abnormalities, increased fall risk, reduced quality of life, psychological impact due to limitations).
Probability of Full Recovery
Very low (no complete recovery; management aims to alleviate symptoms and improve function; surgery can offer significant improvement but doesn't restore the original joint).
Underlying Disease Risk
Moderate (often associated with age, obesity, genetic predisposition, previous hip injury, developmental hip disorders, or other systemic inflammatory conditions).